The global anti-inflammatory therapeutics market is witnessing sustained growth as the prevalence of chronic inflammatory and autoimmune diseases continues to rise globally. According to the latest analysis by Straits Research, the global anti-inflammatory therapeutics market size was valued at USD 111.78 billion in 2024 and is projected to grow from USD 115.25 billion in 2025...
The Autoinjectors Market is gaining significant momentum as healthcare systems worldwide shift toward patient-centric drug delivery solutions that improve safety, convenience, and treatment adherence. Valued at USD 1,102.32 million in 2024, the market is projected to expand at a robust CAGR of 13.90% from 2025 to 2032. This growth is fueled by the rising prevalence of chronic diseases,...
The Upadacitinib API Market research report highlights market research and industry analysis driven by in-depth business relevant news.
Precision Business Insights has published a report on the global Upadacitinib API Market, estimating its value at USD 8,316.4 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% over the forecast period 2025-2031. The...
Precision Business Insights has published a report on the global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, estimating its value at USD 2,623.8 million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 0.8% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a...
[Hyderabad, March 26th, 2025]– – The Rheumatoid Arthritis (RA) drugs market is experiencing robust growth, driven by the rising prevalence of RA, the expansion of biologic therapies, and improved patient access to targeted immune-modulating treatments. Valued at USD XX billion in 2019, the market reached USD XX billion in 2023 and is projected to expand at a CAGR of XX% from 2024 to...
[Hyderabad, March 26th, 2025]– The Adalimumab drugs market is witnessing rapid expansion, fueled by competition from biosimilars, a rising prevalence of autoimmune diseases, and advancements in the administration of biologic drugs. Valued at USD XX billion in 2019, the market reached USD XX billion in 2023 and is projected to grow at a CAGR of XX% from 2024 to 2031, ultimately reaching...
Precision Business Insights has published a report on the global scleritis market, estimating its value at USD 3.42 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements...
The report "Rheumatology Therapeutics Market by Drug Class (Disease Modifying Anti Rheumatic Drugs (Synthetic, Biologic), Non-Steroidal Anti Inflammatory Drugs (NSAIDs), Corticosteroids, Others), by Disorder (Rheumatoid Arthritis, Gout, Ankylosing Spondylitis, Osteo Arthritis, Others), by Route of Administration (Oral, Parenteral, Topical), by Distribution Channel (Hospital Pharmacies, Retail...
According to the Market Statsville Group (MSG), the global infliximab market size is expected to grow at a CAGR of 11.3% from 2023 to 2033.
The increasing prevalence of inflammatory diseases such as Crohn's disease and ulcerative colitis are major driving factors for the infliximab market. For instance, according to Crohn's and Colitis Foundation, approximately 3 million...
Autoimmune Disease Testing Market size was valued at USD 10.2 billion in 2022 and it is expected to be worth around USD 22.18 billion by 2030 growing at a remarkable GAGR of 10.2% over the forecast period 2023-2030.
Drivers of Market Surge:
Rising burden of autoimmune diseases: An estimated 5% of the global population suffers from autoimmune diseases, with conditions...
Biosimilars Market Scope
According to Market Research Future (MRFR), the biosimilars market trends report has valued the industry size USD 23.97 billion in 2022 and is projected to grow from USD 29.70 Billion in 2023 to USD 161.95 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 23.90% during the forecast period (2023 - 2032).
Biosimilars Market: Latest News and...
Clinical Trials Market
Clinical Trials Market Share is expected to reach USD 47,500 Million by 2030 at 5.70% CAGR during the forecast period 2022-2030.
Growth is projected to be propelled by an increasing incidence of diabetes, rheumatoid arthritis, multiple sclerosis and many other chronic diseases. In some regions, due to the increasing prevalence of infectious and tropical diseases, a...